Lafora Disease: Report of a Rare Entity
Open Access
- 28 January 2020
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 12 (1) , e6793
Abstract
Lafora disease is a rare, genetic, glycogen metabolism disorder inherited as autosomal recessive characterized by the presence of inclusion bodies, known as Lafora bodies, within the cytoplasm of the cells in the heart, liver, muscle, and skin. Lafora disease presents as a neurodegenerative disorder that causes impairment in the development of cerebral cortical neurons. We present here a case of Lafora disease that presented with progressive myoclonus epilepsy (PME) and investigated at our center. She was diagnosed to have Lafora disease with typical histological findings on skin biopsy and was found to be positive for the pathogenic mutation on genetic testing.Keywords
This publication has 11 references indexed in Scilit:
- Lafora disease — from pathogenesis to treatment strategiesNature Reviews Neurology, 2018
- Lafora diseaseEpileptic Disorders, 2016
- Neuroimaging of epilepsy2016
- Progressive Myoclonus EpilepsiesSeminars in Neurology, 2015
- Lafora disease: A case report, pathologic and genetic studyIndian Journal of Pathology and Microbiology, 2011
- Typical progression of myoclonic epilepsy of the Lafora type: a case reportNature Clinical Practice Neurology, 2008
- Lafora Progressive Myoclonus Epilepsy: Disease Course Homogeneity in a Genetic IsolateJournal of Child Neurology, 2007
- Guidelines for the use of EEG methodology in the diagnosis of epilepsyActa Neurologica Scandinavica, 2002
- Lafora disease: Diagnosis by skin biopsyJournal of the American Academy of Dermatology, 1999
- Diagnosis by axilla skin biopsy in an early case of Lafora's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1992